Thromb Haemost 1976; 35(02): 386-395
DOI: 10.1055/s-0038-1647933
Original Article
Schattauer GmbH

Various Prothrombin Complex Concentrates and their Effect on Coagulation and Fibrinolysis In Vivo

U Hedner
1   Coagulation Laboratory, University of Lund, Allmänna Sjukhuset, Malmö, Sweden
,
I.M Nilsson
1   Coagulation Laboratory, University of Lund, Allmänna Sjukhuset, Malmö, Sweden
,
S.-E Bergentz
1   Coagulation Laboratory, University of Lund, Allmänna Sjukhuset, Malmö, Sweden
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received 24. Oktober 1975

Accepted 20. November 1975

Publikationsdatum:
02. Juli 2018 (online)

Zoom Image

Summary

Thromboembolic complications occurring in patients treated with factor IX concentrates have been reported. To study the thrombogenicity various types of factor IX concentrates (50 or 100 units F. IX/kg bodyweight) have been infused in dogs. As control albumin was given. The various components of the coagulation and fibrinolytic system have been assayed before the infusion and at various intervals after the end of infusion (0, 1,4 and 24 hrs). Konyne resulted in marked activation of the coagulation process with decrease of platelets, fibrinogen, F. VIII and appearance of FDP and positive ethanol gelation test. Pro thro mplex and Pre-conativ gave no significant changes. Preconativ is prepared without addition of heparin during the procedure.